Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2009
Date: 2010-09-02
Institutions: Standing Committee of the EFTA States
Subjects: EFTA countries, European Economic Area, market approval, medicinal product, withdrawal from the market








C_2010237EN.01000201.xml










2.9.2010   


EN


Official Journal of the European Union


C 237/2





Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2009
2010/C 237/02

Subcommittee I on the free movement of goods


To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July-31 December 2009, at their meeting on 30 April 2010:







Annex I


—


List of new marketing authorisations




Annex II


—


List of renewed marketing authorisations




Annex III


—


List of extended marketing authorisations




Annex IV


—


List of withdrawn marketing authorisations




Annex V


—


List of suspended marketing authorisations






ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July-31 December 2009:








EU-Number


Product


Country


Date of authorisation




EU/1/06/361/001/NO-002/NO


Luminity


Norway


20.8.2009




EU/1/07/436/001-002


Isentress


Liechtenstein


31.8.2009




EU/1/09/575/001-060


Copalia HCT


Liechtenstein


31.12.2009




EU/1/09/511/001-004


Conbriza


Liechtenstein


31.10.2009




EU/1/09/515/001-004/IS


Controloc Control


Iceland


7.9.2009




EU/1/09/516/001/NO


Somac


Norway


13.7.2009




EU/1/09/516/001-004/IS


Somac Control


Iceland


7.9.2009




EU/1/09/516/002/NO


Pantoloc


Norway


13.7.2009




EU/1/09/516/003/NO


Pantecta


Norway


13.7.2009




EU/1/09/516/004/NO


Controloc


Norway


13.7.2009




EU/1/09/517/001/NO-002/NO


Pantozol


Norway


9.7.2009




EU/1/09/517/001-004/IS


Pantozol Control


Iceland


7.9.2009




EU/1/09/518/001-004/IS


Pantecta Control


Iceland


7.9.2009




EU/1/09/519/001-004/IS


Pantoloc Control


Iceland


7.9.2009




EU/1/09/521/001/NO-007/NO


Renvela


Norway


7.10.2009




EU/1/09/521/001-007/IS


Renvela


Iceland


4.9.2009




EU/1/09/523/001/NO-002/NO


Modigraf


Norway


21.10.2009




EU/1/09/523/001-002/IS


Modigraf


Iceland


23.7.2009




EU/1/09/524/001/NO-002/NO


Qutenza


Norway


5.8.2009




EU/1/09/524/001-002/IS


Qutenza


Iceland


21.7.2009




EU/1/09/525/001/NO-046/NO


Nimvastid


Norway


2.11.2009




EU/1/09/526/001/IS


Iressa


Iceland


11.9.2009




EU/1/09/526/001/NO


Iressa


Norway


2.9.2009




EU/1/09/527/001/NO-016/NO


Ribaverin Teva Pharma


Norway


12.8.2009




EU/1/09/527/001-016


Ribavirin Teva Pharma BV


Liechtenstein


31.8.2009




EU/1/09/527/001-016/IS


Ribavirin Teva Pharma BV


Iceland


17.9.2009




EU/1/09/528/001


Nymusa


Liechtenstein


31.8.2009




EU/1/09/528/001/IS


Nymusa


Iceland


17.9.2009




EU/1/09/528/001/NO


Nymusa


Norway


12.8.2009




EU/1/09/529/001/NO-005/NO


Victoza


Norway


4.8.2009




EU/1/09/529/001-005


Victoza


Liechtenstein


31.8.2009




EU/1/09/529/001-005/IS


Victoza


Iceland


15.9.2009




EU/1/09/530/001/NO-015/NO


Repaglinide Teva


Norway


12.8.2009




EU/1/09/530/001-015


Repaglinide Teva


Liechtenstein


31.8.2009




EU/1/09/530/001-015/IS


Repaglinide Teva


Iceland


11.9.2009




EU/1/09/531/001/NO-009/NO


Instanyl


Norway


17.8.2009




EU/1/09/531/001-009


Instanyl


Liechtenstein


31.8.2009




EU/1/09/531/001-009/IS


Instanyl


Iceland


24.9.2009




EU/1/09/532/001/NO-007/NO


Clopidogrel Acino


Norway


25.8.2009




EU/1/09/532/001-007


Clopidogrel Acino


Liechtenstein


31.8.2009




EU/1/09/532/001-007/IS


Clopidogrel Acino


Iceland


24.9.2009




EU/1/09/533/001/NO-003/NO


Vedrop


Norway


20.8.2009




EU/1/09/533/001-003


Vedrop


Liechtenstein


31.8.2009




EU/1/09/533/001-003/IS


Vedrop


Iceland


5.11.2009




EU/1/09/534/001/NO-007/NO


Clopidogrel Hexal


Norway


25.8.2009




EU/1/09/534/001-007


Clopidogrel Hexal


Liechtenstein


31.8.2009




EU/1/09/534/001-007/IS


Clopidogrel Hexal


Iceland


28.9.2009




EU/1/09/535/001/NO-014/NO


Grepid


Norway


20.8.2009




EU/1/09/535/001-014


Grepid


Liechtenstein


31.8.2009




EU/1/09/535/001-014/IS


Grepid


Iceland


9.9.2009




EU/1/09/536/001/NO-002/NO


Topotecan Actavis


Norway


26.8.2009




EU/1/09/536/001-002


Topotecan Actavis


Liechtenstein


31.8.2009




EU/1/09/536/001-002/IS


Topotecan Actavis


Iceland


29.9.2009




EU/1/09/537/001


Mozobil


Liechtenstein


31.8.2009




EU/1/09/537/001/IS


Mozobil


Iceland


14.10.2009




EU/1/09/537/001/NO


Mozobil


Norway


10.8.2009




EU/1/09/538/001/NO-006/NO


Afinitor


Norway


10.8.2009




EU/1/09/538/001-006


Afinitor


Liechtenstein


31.8.2009




EU/1/09/538/001-006/IS


Afinitor


Iceland


15.10.2009




EU/1/09/539/001/NO-004/NO


Samsca


Norway


21.9.2009




EU/1/09/539/001-004


Samsca


Liechtenstein


31.8.2009




EU/1/09/539/001-004/IS


Samsca


Iceland


22.9.2009




EU/1/09/540/001/NO-009/NO


Clopidogrel Teva


Norway


20.8.2009




EU/1/09/540/001-009


Clopidogrel Teva


Liechtenstein


31.8.2009




EU/1/09/540/001-009/IS


Clopidogrel Teva


Iceland


29.9.2009




EU/1/09/541/001/NO-007/NO


Clopidogrel ratiopharm GmbH


Norway


20.8.2009




EU/1/09/541/001-007


Clopidogrel ratiopharm GmbH


Liechtenstein


31.8.2009




EU/1/09/541/001-007/IS


Clopidogrel ratiopharm GmbH


Iceland


24.9.2009




EU/1/09/542/001/NO-007/NO


Clopidogrel 1A Pharma


Norway


20.8.2009




EU/1/09/542/001-007


Clopidogrel 1A Pharma


Liechtenstein


31.8.2009




EU/1/09/542/001-007/IS


Clopidogrel 1A Pharma


Iceland


28.9.2009




EU/1/09/543/001


Cayston


Liechtenstein


31.10.2009




EU/1/09/543/001/IS


Cayston


Iceland


9.11.2009




EU/1/09/543/001/NO


Cayston


Norway


30.9.2009




EU/1/09/544/001/NO-002/NO


Cimzia


Norway


21.10.2009




EU/1/09/544/001-002


Cimzia


Liechtenstein


31.10.2009




EU/1/09/544/001-002/IS


Cimzia


Iceland


24.11.2009




EU/1/09/545/001/NO-010/NO


Onglyza


Norway


8.10.2009




EU/1/09/545/001-010


Onglyza


Liechtenstein


31.10.2009




EU/1/09/545/001-010/IS


Onglyza


Iceland


12.11.2009




EU/1/09/546/001/NO-004/NO


Simponi


Norway


16.10.2009




EU/1/09/546/001-004


Simponi


Liechtenstein


31.10.2009




EU/1/09/546/001-004/IS


Simponi


Iceland


2.11.2009




EU/1/09/547/001/NO-007/NO


Clopidogrel Sandoz


Norway


15.10.2009




EU/1/09/547/001-007


Clopidogrel Sandoz


Liechtenstein


31.10.2009




EU/1/09/547/001-007/IS


Clopidogrel Sandoz


Iceland


25.9.2009




EU/1/09/548/001/NO-007/NO


Clopidogrel Acino Pharma GmbH


Norway


16.11.2009




EU/1/09/548/001-007


Clopidogrel Acino Pharma GmbH


Liechtenstein


31.10.2009




EU/1/09/548/001-007/IS


Clopidogrel Acino Pharma GmbH


Iceland


24.9.2009




EU/1/09/549/001/NO-007/NO


Clopidogrel Acino Pharma


Norway


16.11.2009




EU/1/09/549/001-007


Clopidogrel Acino Pharma


Liechtenstein


31.10.2009




EU/1/09/549/001-007/IS


Clopidogrel Acino Pharma


Iceland


30.11.2009




EU/1/09/550/001/NO-012/NO


Javlor


Norway


21.10.2009




EU/1/09/550/001-012


Javlor


Liechtenstein


31.10.2009




EU/1/09/550/001-012/IS


Javlor


Iceland


10.11.2009




EU/1/09/551/001/NO-012/NO


Vizarsin


Norway


30.9.2009




EU/1/09/551/001-012


Vizarsin


Liechtenstein


31.10.2009




EU/1/09/551/001-012/IS


Vizarsin


Iceland


6.11.2009




EU/1/09/552/001/NO-004/NO


Topotecan Teva


Norway


21.10.2009




EU/1/09/552/001-004


Topotecan Teva


Liechtenstein


31.10.2009




EU/1/09/552/001-004/IS


Topotecan Teva


Iceland


10.11.2009




EU/1/09/553/001/NO-010/NO


Zyllt


Norway


15.10.2009




EU/1/09/553/001-010


Zyllit


Liechtenstein


31.10.2009




EU/1/09/553/001-010/IS


Zyllt


Iceland


5.11.2009




EU/1/09/554/001/NO-007/NO


Clopidogrel ratiopharm


Norway


28.10.2009




EU/1/09/554/001-007


Clopidogrel ratiopharm


Liechtenstein


31.10.2009




EU/1/09/554/001-007/IS


Clopidogrel ratiopharm


Iceland


27.11.2009




EU/1/09/555/001/NO-009/NO


Clopidogrel TAD


Norway


15.10.2009




EU/1/09/555/001-009


Clopidogrel TAD


Liechtenstein


31.10.2009




EU/1/09/555/001-009/IS


Clopidogrel TAD


Iceland


2.12.2009




EU/1/09/556/001/NO-009/NO


Clopidogrel Krka


Norway


15.10.2009




EU/1/09/556/001-009


Clopidogrel Krka


Liechtenstein


31.10.2009




EU/1/09/556/001-009/IS


Clopidogrel Krka


Iceland


17.11.2009




EU/1/09/557/001/NO-009/NO


Clopidogrel Qualimed


Norway


15.10.2009




EU/1/09/557/001-009


Clopidogrel Qualimed


Liechtenstein


31.10.2009




EU/1/09/557/001-009/IS


Clopidogrel Qualimed


Iceland


3.11.2009




EU/1/09/558/001/NO-010/NO


Zylagren


Norway


30.9.2009




EU/1/09/558/001-010


Zylagren


Liechtenstein


31.10.2009




EU/1/09/558/001-010/IS


Zylagren


Iceland


5.11.2009




EU/1/09/559/001/NO-009/NO


Clopidogrel Mylan


Norway


15.10.2009




EU/1/09/559/001-009


Clopidogrel Mylan


Liechtenstein


31.10.2009




EU/1/09/559/001-009/IS


Clopidogrel Mylan


Iceland


29.9.2009




EU/1/09/560/001/NO-009/NO


Clopidogrel Dura


Norway


15.10.2009




EU/1/09/560/001-009


Clopidogrel Dura


Liechtenstein


31.10.2009




EU/1/09/560/001-009/IS


Clopidogrel Dura


Iceland


2.11.2009




EU/1/09/561/001/NO-009/NO


Clopidogrel HCS


Norway


15.10.2009




EU/1/09/561/001-009


Clopidogrel HCS


Liechtenstein


31.10.2009




EU/1/09/561/001-009/IS


Clopidogrel HCS


Iceland


3.11.2009




EU/1/09/562/001/NO-009/NO


Zopya


Norway


30.9.2009




EU/1/09/562/001-009


Zopya


Liechtenstein


31.10.2009




EU/1/09/562/001-009/IS


Zopya


Iceland


3.11.2009




EU/1/09/563/001


ChondroCelect


Liechtenstein


31.10.2009




EU/1/09/563/001/IS


ChondroCelect


Iceland


30.11.2009




EU/1/09/563/001/NO


ChondroCelect


Norway


22.10.2009




EU/1/09/564/001/NO-002/NO


Ilaris


Norway


10.11.2009




EU/1/09/564/001-002


Ilaris


Liechtenstein


31.10.2009




EU/1/09/564/001-002/IS


Ilaris


Iceland


20.11.2009




EU/1/09/565/001/NO-028/NO


Biopoin


Norway


11.11.2009




EU/1/09/565/001-028


Biopoin


Liechtenstein


31.10.2009




EU/1/09/565/001-028/IS


Biopoin


Iceland


20.11.2009




EU/1/09/566/001/NO-005/NO


Lamivudine Teva


Norway


16.11.2009




EU/1/09/566/001-005


Lamivudine Teva


Liechtenstein


31.10.2009




EU/1/09/566/001-005/IS


Lamivudine Teva


Iceland


20.11.2009




EU/1/09/568/001/NO-018/NO


Klopidogrel Mylan Pharma


Norway


16.11.2009




EU/1/09/568/001-018


Clopidogrel Mylan Pharma


Liechtenstein


31.10.2009




EU/1/09/568/001-018/IS


Clopidogrel Mylan Pharma


Iceland


27.11.2009




EU/1/09/569/001/NO-060/NO


Exforge HCT


Norway


2.11.2009




EU/1/09/569/001-060


Exforge HCT


Liechtenstein


31.10.2009




EU/1/09/569/001-060/IS


Exforge HCT


Iceland


18.11.2009




EU/1/09/570/001/NO-060/NO


Imprida HCT


Norway


24.11.2009




EU/1/09/570/001-060


Imprida HCT


Liechtenstein


31.10.2009




EU/1/09/570/001-060/IS


Imprida HCT


Iceland


18.11.2009




EU/1/09/571/001


Pandemic Influenza Vaccine H5N1 Baxter


Liechtenstein


31.12.2009




EU/1/09/571/001/NO


Pandemic Influenza Vaccine H5N1 Baxter


Norway


2.12.2009




EU/1/09/572/001/NO-009/NO


Alendronate Sodium and Colecalciferol MSD


Norway


14.12.2009




EU/1/09/572/001-009


Alendronate Sodium and Colecalciferol MSD


Liechtenstein


31.10.2009




EU/1/09/572/001-009/IS


Alendronate Sodium and Colecalciferol MSD


Iceland


26.11.2009




EU/1/09/573/001/NO-028/NO


Eporatio


Norway


11.11.2009




EU/1/09/573/001-028


Eporatio


Liechtenstein


31.12.2009




EU/1/09/573/001-028/IS


Eporatio


Iceland


20.11.2009




EU/1/09/574/001/NO-060/NO


Dafiro HCT


Norway


25.11.2009




EU/1/09/574/001-060


Dafiro HCT


Liechtenstein


31.12.2009




EU/1/09/574/001-060/IS


Dafiro HCT


Iceland


25.11.2009




EU/1/09/575/001/NO-060/NO


Copalia


Norway


25.11.2009




EU/1/09/575/001-060/IS


Copalia HCT


Iceland


26.11.2009




EU/1/09/576/001/NO-039/NO


Irbesartan Teva


Norway


11.11.2009




EU/1/09/576/001-039


Irbesartan Teva


Liechtenstein


31.12.2009




EU/1/09/576/001-039/IS


Irbesartan Teva


Iceland


25.11.2009




EU/1/09/577/001-004


Foclivia


Liechtenstein


31.12.2009




EU/1/09/578/001


Pandemic Influenza Vaccine (H5N1) GlaxoSmithKline Biologicals


Liechtenstein


31.12.2009




EU/1/09/578/001/NO


Pandemivaksine mot influensa


Norway


1.12.2009




EU/1/09/579/001/NO-018/NO


Repaglinide Krka


Norway


10.12.2009




EU/1/09/579/001-018


Repaglinide Krka


Liechtenstein


31.12.2009




EU/1/09/579/001-018/IS


Repaglinide Krka


Iceland


17.11.2009




EU/1/09/580/001/NO-018/NO


Enyglid


Norway


13.11.2009




EU/1/09/580/001-018


Enyglid


Liechtenstein


31.10.2009




EU/1/09/580/001-018/IS


Enyglid


Iceland


17.11.2009




EU/1/09/581/001/NO-002/NO


Resolor


Norway


14.12.2009




EU/1/09/581/001-002


Resolor


Liechtenstein


31.10.2009




EU/1/09/581/001-002/IS


Resolor


Iceland


18.11.2009




EU/1/09/582/001


Arcalyst


Liechtenstein


31.10.2009




EU/1/09/582/001/IS


Arcalyst


Iceland


20.11.2009




EU/1/09/582/001/NO


Arcalyst


Norway


11.11.2009




EU/1/09/583/001-072/IS


Irbesartan/Hydrochlorothiazide Teva


Iceland


17.12.2009




EU/1/09/584/001/NO-018/NO


Sildenafil Teva


Norway


15.12.2009




EU/1/09/584/001-018/IS


Sildenafil Teva


Iceland


23.12.2009




EU/1/09/586/001-010/IS


Oslif Breezhaler


Iceland


22.12.2009




EU/1/09/590/001-006/IS


Prevenar 13


Iceland


16.12.2009




EU/1/09/591/001/NO-004/NO


Multaq


Norway


15.12.2009




EU/1/09/591/001-004/IS


Multaq


Iceland


21.12.2009




EU/1/09/593/001-010/IS


Onbrez Breezhaler


Iceland


22.12.2009




EU/1/09/594/001-010/IS


Hirobriz Breezhaler


Iceland


22.12.2009




EU/1/97/045/001/NO-004/NO


Helicobacter Test INFAI


Norway


21.9.2009




EU/2/07/076/001-004/IS


Nobilis Influenza H5N6


Iceland


7.9.2009




EU/2/08/083/001/IS


Equioxx


Iceland


21.7.2009




EU/2/08/086/001-003/IS


Duvaxyn WNV


Iceland


4.11.2009




EU/2/09/095/001-003/IS


Improvac


Iceland


3.11.2009




EU/2/09/096/001-002/IS


Leucogen


Iceland


11.9.2009




EU/2/09/097/001/NO-002/NO


Leucofeligen FeLV/RCP


Norway


13.7.2009




EU/2/09/097/001-002


Leucofeligen FeLV/RCP


Liechtenstein


31.8.2009




EU/2/09/097/001-002/IS


Leucofeligen FeLV/RCP


Iceland


11.9.2009




EU/2/09/098/001


Melovem


Liechtenstein


31.8.2009




EU/2/09/098/001/IS


Melovem


Iceland


22.9.2009




EU/2/09/098/001/NO


Melovem


Norway


4.9.2009




EU/2/09/099/001/NO-006/NO


Suvaxyn PCV vet


Norway


18.8.2009




EU/2/09/099/001-006


Suvaxyn PCV


Liechtenstein


31.8.2009




EU/2/09/099/001-006/IS


Suvaxyn PCV


Iceland


28.9.2009




EU/2/09/100/001/NO-003/NO


Palladia


Norway


29.10.2009




EU/2/09/100/001-003


Palladia


Liechtenstein


31.10.2009




EU/2/09/100/001-003/IS


Palladia


Iceland


11.11.2009







ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July-31 December 2009:








EU-Number


Product


Country


Date of authorisation




EU/1/03/264/001/NO


Zevalin


Norway


21.8.2009




EU/1/03/270/001/NO-003/NO


Kentera


Norway


9.7.2009




EU/1/04/275/001/NO-002/NO


Litak


Norway


1.7.2009




EU/1/04/276/001/NO-036/NO


Abilify


Norway


13.7.2009




EU/1/04/276/001-020,024-036/IS


Abilify


Iceland


20.7.2009




EU/1/04/277/001/NO-004/NO


Tachosil


Norway


24.9.2009




EU/1/04/277/001-004/IS


Tachosil


Iceland


2.9.2009




EU/1/04/279/001/NO-036/NO


Lyrica


Norway


29.7.2009




EU/1/04/279/001-025,030-043/IS


Lyrica


Iceland


21.9.2009




EU/1/04/280/001/NO-008/NO


Yentreve


Norway


18.8.2009




EU/1/04/280/001-008/IS


Yentreve


Iceland


14.9.2009




EU/1/04/280/001-008


Yentreve


Liechtenstein


31.8.2009




EU/1/04/281/001-005/IS


Erbitux


Iceland


9.9.2009




EU/1/04/282/001/NO-002/NO


Telzir


Norway


10.8.2009




EU/1/04/282/001-002/IS


Telzir


Iceland


21.7.2009




EU/1/04/283/008/NO-012/NO


Ariclaim


Norway


24.8.2009




EU/1/04/283/008-012/IS


Ariclaim


Iceland


14.9.2009




EU/1/04/284/001


Pedea


Liechtenstein


31.8.2009




EU/1/04/284/001/IS


Pedea


Iceland


28.9.2009




EU/1/04/284/001/NO


Pedea


Norway


20.10.2009




EU/1/04/285/001/NO-036/NO


Apidra


Norway


9.9.2009




EU/1/04/285/001-036


Apidra


Liechtenstein


31.8.2009




EU/1/04/285/001-036/IS


Apidra


Iceland


2.10.2009




EU/1/04/286/001/NO-002/NO


Wilzin


Norway


26.10.2009




EU/1/04/286/001-002


Wilzin


Liechtenstein


31.10.2009




EU/1/04/286/001-002/IS


Wilzin


Iceland


18.11.2009




EU/1/04/287/001/NO-006/NO


Osseor


Norway


18.12.2009




EU/1/04/287/001-006


Osseor


Liechtenstein


31.12.2009




EU/1/04/287/001-006/IS


Osseor


Iceland


29.11.2009




EU/1/04/288/001/NO-006/NO


Protelos


Norway


28.12.2009




EU/1/04/288/001-006/IS


Protelos


Iceland


29.11.2009




EU/1/04/289/001/NO-002/NO


Angiox


Norway


9.7.2009




EU/1/04/289/001-002


Angiox


Liechtenstein


31.8.2009




EU/1/04/289/001-002/IS


Angiox


Iceland


9.12.2009




EU/1/04/290/001-002


Alimta


Liechtenstein


31.10.2009




EU/1/04/290/001-002/IS


Alimta


Iceland


24.9.2009




EU/1/04/292/001/NO-012/NO


Mimpara


Norway


6.10.2009




EU/1/04/292/001-012


Mimpara


Liechtenstein


31.10.2009




EU/1/04/292/001-012/IS


Mimpara


Iceland


12.11.2009




EU/1/04/294/001/NO-028/NO


Emselex


Norway


21.10.2009




EU/1/04/294/001-028/IS


Emselex


Iceland


5.11.2009




EU/1/04/295/001


Xagrid


Liechtenstein


31.12.2009




EU/1/04/295/001/NO


Xagrid


Norway


16.12.2009




EU/1/04/295/001/IS


Xagrid


Iceland


10.12.2009




EU/1/04/296/001/NO-009/NO


Cymbalta


Norway


24.8.2009




EU/1/04/296/001-009/IS


Cymbalta


Iceland


14.9.2009




EU/1/04/297/001/NO-006/NO


Xeristar


Norway


27.10.2009




EU/1/04/297/001-008/IS


Xeristar


Iceland


14.9.2009




EU/1/04/298/001-003/IS


Kivexa


Iceland


17.12.2009




EU/1/04/304/001-007


Azilect


Liechtenstein


31.10.2009




EU/1/04/304/001-007/IS


Azilect


Iceland


11.11.2009




EU/1/06/367/001-012/IS


Diacomit


Iceland


21.12.2009




EU/1/07/423/001/NO-003/NO


Vectibix


Norway


16.7.2009




EU/1/07/436/001-002/IS


Isentress


Iceland


27.8.2009




EU/1/08/468/001


Intelence


Liechtenstein


31.8.2009




EU/1/08/468/001/IS


Intelence


Iceland


22.10.2009




EU/1/08/468/001/NO


Intelence


Norway


20.8.2009




EU/1/09/288/001-006


Protelos


Liechtenstein


31.12.2009




EU/1/09/555/002/NO


Alimta


Norway


23.9.2009




EU/1/97/044/001/NO-008/NO


Simponi


Norway


20.10.2009




EU/1/97/044/001/NO-008/NO


Tasmar


Norway


20.10.2009




EU/1/97/044/001-008


Tasmar


Liechtenstein


31.10.2009




EU/1/97/044/001-008/IS


Tasmar


Iceland


15.10.2009




EU/1/99/100/001-003/IS


Cetrotide


Iceland


30.11.2009




EU/1/99/103/001/NO-004/NO


Refacto AF


Norway


2.7.2009




EU/1/99/107/001/NO-004/NO


Rebetol


Norway


30.7.2009




EU/1/99/108/001/NO-003/NO


Ferriprox


Norway


6.10.2009




EU/1/99/108/001-003


Ferriprox


Liechtenstein


31.10.2009




EU/1/99/108/001-003/IS


Ferriprox


Iceland


11.11.2009




EU/1/99/109/001/NO-002/NO


Integrilin


Norway


10.8.2009




EU/1/99/109/001-002


Integrilin


Liechtenstein


31.8.2009




EU/1/99/109/001-002/IS


Integrilin


Iceland


30.9.2009




EU/1/99/112/001/NO-002/NO


Ziagen


Norway


26.8.2009




EU/1/99/112/001-002/IS


Ziagen


Iceland


12.7.2009




EU/1/99/113/001-004


Paxene


Liechtenstein


31.8.2009




EU/1/99/113/001-004/IS


Paxene


Iceland


27.11.2009




EU/1/99/114/001/NO-003/NO


Zeffix


Norway


16.9.2009




EU/1/99/114/001-003


Zeffix


Liechtenstein


31.10.2009




EU/1/99/114/001-003/IS


Zeffix


Iceland


15.10.2009




EU/1/99/116/001/NO-005/NO


Remicade


Norway


2.10.2009




EU/1/99/116/001-005


Remicade


Liechtenstein


31.8.2009




EU/1/99/116/001-005/IS


Remicade


Iceland


8.9.2009




EU/1/99/117/001/NO-002/NO


Synagis


Norway


28.9.2009




EU/1/99/117/001-002


Synagis


Liechtenstein


31.8.2009




EU/1/99/117/001-002/IS


Synagis


Iceland


22.10.2009




EU/1/99/118/001/NO-009/NO


Arava


Norway


5.10.2009




EU/1/99/118/001-010


Arava


Liechtenstein


31.8.2009




EU/1/99/118/001-010/IS


Arava


Iceland


15.9.2009




EU/1/99/119/001,003,005-015/IS


NovoRapid


Iceland


26.8.2009




EU/1/99/120/001/NO-004/NO


Ammonaps


Norway


22.10.2009




EU/1/99/120/001-004


Ammonaps


Liechtenstein


31.10.2009




EU/1/99/120/001-004/IS


Ammonaps


Iceland


17.11.2009




EU/1/99/126/001-021/IS


Enbrel


Iceland


21.12.2009




EU/2/04/043/001/NO


Equilis StrepE


Norway


30.7.2009




EU/2/04/044/001/NO-010/NO


Aivlosin


Norway


18.9.2009




EU/2/04/044/001-010


Aivlosin


Liechtenstein


31.10.2009




EU/2/04/044/001-010/IS


Aivlosin


Iceland


7.10.2009




EU/2/04/045/001-007/IS


Previcox


Iceland


21.9.2009




EU/2/04/046/001-003


Nobivac Piro


Liechtenstein


31.8.2009




EU/2/04/046/001-003/IS


Nobivac Piro


Iceland


23.9.2009




EU/2/98/009/001-006/IS


Suvaxyn Aujeszky 783+O/W


Iceland


5.11.2009




EU/2/98/010/017-18,21-24/NO


Econor


Norway


24.11.2009




EU/2/99/014//001-012


Stronghold


Liechtenstein


31.10.2009




EU/2/99/014/001-012/IS


Stronghold


Iceland


16.12.2009




EU/2/99/015/001-002


Oxyglobin


Liechtenstein


31.10.2009




EU/2/99/015/001-002/IS


Oxyglobin


Iceland


30.11.2009







ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July-31 December 2009:








EU-Number


Product


Country


Date of authorisation




EU/1/00/146/031-032


Keppra


Liechtenstein


31.10.2009




EU/1/00/155/007/IS


Luveris


Iceland


22.7.2009




EU/1/00/155/007/NO


Luveris


Norway


12.8.2009




EU/1/01/185/074-099


Aranesp


Liechtenstein


31.12.2009




EU/1/01/195/022/NO-025/NO


Liprolog Basal


Norway


13.8.2009




EU/1/01/195/026/NO-027/NO


Liprolog Basal Kwik-Pen


Norway


13.8.2009




EU/1/02/220/006


Tracleer


Liechtenstein


31.8.2009




EU/1/02/220/006/IS


Tracleer


Iceland


16.9.2009




EU/1/02/227/004


Neulasta


Liechtenstein


31.10.2009




EU/1/05/315/002/IS


Aptivus


Iceland


26.8.2009




EU/1/05/315/002/NO


Aptivus


Norway


12.8.2009




EU/1/06/347/007/NO-008/NO


Sutent


Norway


7.9.2009




EU/1/06/347/007-008/IS


Sutent


Iceland


9.9.2009




EU/1/06/380/004/NO-005/NO


Prezista


Norway


12.8.2009




EU/1/06/380/004-005/IS


Prezista


Iceland


10.9.2009




EU/1/07/384/003-004/IS


Docetaxel Winthrop


Iceland


28.12.2009




EU/1/07/410/021/NO-026/NO


Binocrit


Norway


27.10.2009




EU/1/07/410/021-026


Binocrit


Liechtenstein


31.10.2009




EU/1/07/410/021-026/IS


Binocrit


Iceland


15.10.2009




EU/1/07/411/021/NO-026/NO


Epoetin alfa Hexal


Norway


23.10.2009




EU/1/07/411/021-026


Epoetin alfa Hexal


Liechtenstein


31.10.2009




EU/1/07/412/021-026/IS


Abseamed


Iceland


21.12.2009




EU/1/07/416/002


Ecalta


Liechtenstein


31.8.2009




EU/1/07/416/002/IS


Ecalta


Iceland


25.9.2009




EU/1/07/416/002/NO


Ecalta


Norway


25.8.2009




EU/1/08/446/005-006


Privigen


Liechtenstein


31.8.2009




EU/1/08/453/002


Prepandrix


Liechtenstein


31.8.2009




EU/1/08/453/002/IS


Prepandrix


Iceland


9.11.2009




EU/1/08/489/002


Opgenra


Liechtenstein


31.10.2009




EU/1/08/497/003-004


Nplate


Liechtenstein


31.10.2009




EU/1/95/002/003-004/IS


Taxotere


Iceland


23.12.2009




EU/1/95/003/009-010


Betaferon


Liechtenstein


31.10.2009




EU/1/97/050/013/NO-027/NO


Sifrol


Norway


20.10.2009




EU/1/97/050/013-027


Sifrol


Liechtenstein


31.10.2009




EU/1/97/050/013-027/IS


Sifrol


Iceland


12.11.2009




EU/1/97/051/013/NO-027/NO


Mirapexin


Norway


22.10.2009




EU/1/97/051/013-027


Mirapexin


Liechtenstein


31.10.2009




EU/1/97/051/013-027/IS


Mirapexin


Iceland


12.11.2009




EU/1/99/126/019-021


Enbrel


Liechtenstein


31.8.2009




EU/2/04/044/009/NO-010/NO


Aivlosin


Norway


15.7.2009




EU/2/04/044/009-010/IS


Aivlosin


Iceland


2.9.2009




EU/2/05/053/003


Naxcel


Liechtenstein


31.10.2009




EU/2/05/053/003/IS


Naxcel


Iceland


13.11.2009




EU/2/05/053/003/NO


Naxcel


Norway


26.10.2009




EU/2/06/070/004


Meloxidyl


Liechtenstein


31.10.2009




EU/2/06/070/004/NO


Meloxidyl


Norway


20.10.2009




EU/2/07/078/004-006


Zactran


Liechtenstein


31.8.2009




EU/2/07/078/005/NO-008/NO


Rheumocam


Norway


26.10.2009




EU/2/07/078/005-008/IS


Rheumocam


Iceland


13.11.2009




EU/2/078/005-008


Rheumocam


Liechtenstein


31.10.2009




EU/2/98/010/004/NO-006/NO


Econor


Norway


24.11.2009







ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July-31 December 2009:








EU-Number


Product


Country


Date of withdrawal




EU/1/01/175/001-021/IS


Trazec


Iceland


15.12.2009




EU/1/05/321/001/IS


Posaconazole SP


Iceland


15.12.2009




EU/1/06/369/001/NO-028/NO


Irbesartan BMS


Norway


1.12.2009




EU/1/06/369/001/NO-028/NO


Irbesartan HCT BMS


Norway


1.12.2009




EU/1/06/369/001/NO-028/NO


Irbesartan BMS


Norway


1.12.2009




EU/1/06/369/001/NO-028/NO


Irbesartan HCT BMS


Norway


1.12.2009




EU/1/06/369/001-028


Irbesartan HCT BMS


Liechtenstein


31.12.2009




EU/1/06/369/001-028/IS


Irbesartan HCT BMS


Iceland


2.12.2009




EU/1/06/375/001-033/IS


Irbesartan BMS


Iceland


2.12.2009




EU/1/07/385/003/NO


Focetria


Norway


19.10.2009




EU/1/07/408/001/NO-020/NO


Tekturna


Norway


17.9.2009




EU/1/07/408/001-020


Tekturna


Liechtenstein


31.10.2009




EU/1/07/408/001-020/IS


Tekturna


Iceland


2.9.2009




EU/1/08/464/001/NO-019/NO


Clopidogrel BMS


Norway


22.12.2009




EU/1/08/464/001-019/IS


Clopidogrel BMS


Iceland


2.12.2009




EU/1/08/464/001-019


Clopidogrel BMS


Liechtenstein


31.12.2009




EU/1/96/024/006NO,007/NO,009/NO


Crixivan


Norway


24.9.2009




EU/1/96/024/006NO,007/NO,009/NO


Crixivan


Norway


24.9.2009




EU/1/99/104/001/IS


Procomvax


Iceland


15.12.2009




EU/1/99/113/001-004/IS


Paxene


Iceland


2.12.2009







ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July-31 December 2009:








EU-Number


Product


Country


Date of suspension




None


None


—


—